EE138 Clinical and Economic Value of a Biosimilar Portfolio to Stakeholders: A Conceptual Framework

Abstract

Authors

GE Fox M Bernauer J Stephens B Jackson J Roth A Shelbaya

Full Text Cite This Article
Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×